Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen

Journal of Diabetes Science and Technology
Ana Maria GomezRichard Buendia

Abstract

Continuous glucose monitoring (CGM) may improve the management of patients with type 2 diabetes hospitalized in the general ward by facilitating the detection of hyper- and hypoglycemic episodes. However, the lack of data on the accuracy and safety of CGM have limited its application. A prospective pilot study was conducted including 38 patients hospitalized in the general ward with a known diagnosis of type 2 diabetes mellitus (DM) and hyperglycemic individuals without a history of DM with a blood sugar of 140-400 mg on admission treated with a basal bolus insulin regimen. Inpatient glycemic control and the incidence of hypoglycemic episodes were compared between detection by CGM of interstitial fluid for up to 6 days and point-of-care (POC) capillary blood glucose monitoring performed pre- and postprandially, before bedtime and at 3 am. No differences in average daily glucose levels were observed between CGM and POC (176.2 ± 33.9 vs 176.6 ± 33.7 mg/dl, P = .828). However, CGM detected a higher number of hypoglycemic episodes than POC (55 vs 12, P < .01). Glucose measurements were clinically valid, with 91.9% of patients falling within the Clarke error grid A and B zones. Our preliminary results indicate that the use of CGM in...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Apr 7, 1998·JPEN. Journal of Parenteral and Enteral Nutrition·J J PomposelliB R Bistrian
Aug 18, 2000·The Journal of Clinical Endocrinology and Metabolism·R LobmannH Lehnert
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Guillermo E UmpierrezAbbas E Kitabchi
Jan 30, 2004·Diabetes Care·Stephen ClementUNKNOWN American Diabetes Association Diabetes in Hospitals Writing Committee
Dec 15, 2007·Metabolism: Clinical and Experimental·Abbas E KitabchiGuillermo E Umpierrez
Mar 26, 2009·The New England Journal of Medicine·Simon FinferJuan J Ronco
Apr 16, 2009·JAMA : the Journal of the American Medical Association·Mikhail KosiborodJohn A Spertus
Jul 21, 2009·Diabetes Technology & Therapeutics·William Clarke, Boris Kovatchev
Jun 19, 2009·Critical Care : the Official Journal of the Critical Care Forum·Sean M BagshawUNKNOWN ANZICS CORE Management Committee
Jul 1, 2009·Diabetes Care·Alexander TurchinMerri L Pendergrass
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Jan 10, 2012·The Journal of Clinical Endocrinology and Metabolism·Guillermo E UmpierrezUNKNOWN Endocrine Society
Sep 21, 2012·The New England Journal of Medicine·Simon FinferBruce G Robinson
Oct 16, 2012·Journal of Diabetes Science and Technology·Baraka FloydGuillermo E Umpierrez
Aug 16, 2014·Journal of Diabetes Science and Technology·Ana Maria Gomez, Guillermo E Umpierrez

❮ Previous
Next ❯

Citations

Apr 22, 2017·Journal of Diabetes Science and Technology·Amisha WalliaUNKNOWN DTS Continuous Glucose Monitoring in the Hospital Panel
May 26, 2017·Diabetes Technology & Therapeutics·Anders L CarlsonRichard M Bergenstal
Jun 12, 2016·Journal of Diabetes Science and Technology·Amisha WalliaUNKNOWN PRIDE Investigators
Dec 22, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·H Thabit, R Hovorka
Oct 6, 2017·Current Diabetes Reports·Paulina CruzGarry S Tobin
Nov 1, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Laure de DeckerBertrand Cariou
Jun 25, 2018·Diabetes Care·Guillermo E Umpierrez, David C Klonoff
Nov 21, 2018·Journal of Diabetes Science and Technology·Grazia Aleppo, Kimberly Webb
Jan 8, 2019·BMJ Open Diabetes Research & Care·Saumeth CardonaGuillermo E Umpierrez
Sep 29, 2020·Journal of Diabetes Science and Technology·Rodolfo J GalindoDavid C Klonoff
Sep 29, 2019·World Journal of Diabetes·Alex Renato MonteroMichelle F Magee
Mar 16, 2017·Journal of Diabetes Science and Technology·David L LevittElias K Spanakis
Jul 30, 2017·Current Diabetes Reports·Kristen Kulasa, Patricia Juang
Jan 3, 2018·Diabetes Technology & Therapeutics·David L LevittKristi D Silver
Dec 15, 2017·Journal of Diabetes Science and Technology·Elias K SpanakisJeffrey C Fink
Aug 31, 2018·Current Diabetes Reports·Medha SatyarenggaElias K Spanakis
Jan 15, 2019·Journal of Diabetes Science and Technology·Meng WangElias K Spanakis
Jan 16, 2021·Current Diabetes Reports·Tiffany YehFelicia A Mendelsohn Curanaj
Dec 29, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay KalraDiana A Nkansah
Mar 5, 2021·Journal of Diabetes Science and Technology·Clémentine DillmannLaurence Kessler
Apr 1, 2021·Endocrinology and Metabolism·M Citlalli Perez-GuzmanDavid C Klonoff
May 12, 2021·Journal of Diabetes Science and Technology·Rebecca Rick LongoJane Jefferie Seley
Aug 9, 2021·Journal of Diabetes and Its Complications·Kristin E CrinerMary T Korytkowski
Oct 27, 2021·Journal of Diabetes Science and Technology·Benjamin Clubbs ColdronSandra MacRury

❮ Previous
Next ❯

Software Mentioned

iPro CareLink
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.